Hims & Hers Health (HIMS) Cash from Financing Activities (2019 - 2026)

Hims & Hers Health has disclosed Cash from Financing Activities across 8 years of filings, most recently posting -$77.9 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$77.9 million, down 238.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $674.8 million (up 771.03% YoY), and the FY2025 annual result was $729.6 million, up 776.55% from the prior year.
• Cash from Financing Activities came in at -$77.9 million for Q1 2026 at Hims & Hers Health, up from -$97.5 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $889.2 million in Q2 2025 to a low of -$97.5 million in Q4 2025.
• The 5-year median for Cash from Financing Activities is -$13.7 million (2024), against an average of $29.4 million.
• Across the five-year window, Cash from Financing Activities slumped 13308.97% in 2022 and jumped 3647.45% in 2025, its largest moves.
• Hims & Hers Health's Cash from Financing Activities stood at -$10.5 million in 2022, then jumped by 62.11% to -$4.0 million in 2023, then plunged by 244.49% to -$13.7 million in 2024, then plunged by 614.34% to -$97.5 million in 2025, then grew by 20.14% to -$77.9 million in 2026.
• The last three Cash from Financing Activities figures came in at -$77.9 million (Q1 2026), -$97.5 million (Q4 2025), and -$39.0 million (Q3 2025), per Business Quant data.